Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Importance Nearly 45 000 human papillomavirus (HPV)-associated cancers are diagnosed
annually in the US. The HPV vaccine has been approved since 2006, but information on the …

Cervical cancer still poses a significant global challenge. Developed countries have
mitigated this challenge by the introduction of structured screening programmes and, more …

Background High-risk human papillomavirus causes cervical cancer. Vaccines have been
developed that significantly reduce the incidence of preinvasive and invasive disease. This …

Background: Human papillomavirus (HPV) vaccination was introduced in 2006 for females
and in 2011 for males. Objective: To estimate vaccine impact and effectiveness against …

Human papillomavirus (HPV) vaccines work by preventing infections prior to natural
exposure. Thus, it is likely more effective at younger ages, and it is important to understand …

HPV-related diseases represent a major cause of morbidity and mortality, although effective
HPV vaccines are available, potentially allowing for the elimination of these malignancies …

Introduction Human papillomavirus (HPV) infection, which poses significant disease burden,
is decreasing following implementation of vaccination programs. Synthesized evidence on …

Video Abstract BACKGROUND AND OBJECTIVES The 9-valent human papillomavirus
(9vHPV) vaccine Phase III immunogenicity study in 9-to 15-year-old boys and girls was …